A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study
The 3-factor prothrombin complex concentrate (3FPCC) may be used off-label to treat refractory bleeding during cardiac surgery in children. This retrospective study examined the rate of clinical complications following the use of 3FPCC. Patients treated with 3FPCC were matched to controls for age, g...
Gespeichert in:
| Veröffentlicht in: | Seminars in cardiothoracic and vascular anesthesia 2020-09, Vol.24 (3), p.227-231 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 231 |
|---|---|
| container_issue | 3 |
| container_start_page | 227 |
| container_title | Seminars in cardiothoracic and vascular anesthesia |
| container_volume | 24 |
| creator | Harris, Andrea D. Hubbard, Richard M. Sam, Rebecca M. Zhang, Xu Salazar, Jorge Gautam, Nischal K. |
| description | The 3-factor prothrombin complex concentrate (3FPCC) may be used off-label to treat refractory bleeding during cardiac surgery in children. This retrospective study examined the rate of clinical complications following the use of 3FPCC. Patients treated with 3FPCC were matched to controls for age, gender, prematurity, weight, cardiopulmonary bypass times, and cross-clamp times. Fifty-nine cases were individually matched to 59 controls based on propensity scores. 3FPCC was not associated with an increased risk of thromboembolic events, mortality, or need for postoperative extracorporeal membrane oxygenator support. These results suggest the safety of 3FPCC when used for refractory bleeding after cardiopulmonary bypass in children undergoing congenital heart surgery. |
| doi_str_mv | 10.1177/1089253219899255 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2334224697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1089253219899255</sage_id><sourcerecordid>2334224697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-2f4312ca29ad68e0f40c20a3e1fe65df6fe318b4274ad1de5857fa176e55f27f3</originalsourceid><addsrcrecordid>eNp1kUtv1DAUhS1ERUthzwp5ySbgR5wHuzCiFKkVqGXWkce-nknl2MF2KvIP-7NwmNIFEqt7pPud48dB6A0l7ymt6w-UNC0TnNG2abMQz9AZbUtSCNFWz7PO62Ldn6KXMd4Rwgij_AU65bQlVcPoGXro8A2k4OMEKg33gDsn7RKHiL3B6QB4G2GVvLiQKvmAvwefDsGPu8HhjR8nC7_ydApcCjJBxCZDN2DCH3zBnyyAHtwedyZBwBsZ9OCn2Y7eyXW9TDJGvIYdBqsDOLx1GsLer55LkCHh2znsISwfcYevZVIH0DkmQpGPzTe3-DbNenmFToy0EV4_znO0vfj8Y3NZXH378nXTXRWK8zoVzJScMiVZK3XVADElUYxIDtRAJbSpDHDa7EpWl1JTDaIRtZG0rkAIw2rDz9G7Y-4U_M8ZYurHISqwVjrwc-wZ5yVjZdXWGSVHVOX_jQFMP4VhzK_uKenX_vp_-8uWt4_p824E_WT4W1gGiiMQ5R76Oz-H3Ff8f-BvizGmHw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2334224697</pqid></control><display><type>article</type><title>A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study</title><source>SAGE Complete A-Z List</source><creator>Harris, Andrea D. ; Hubbard, Richard M. ; Sam, Rebecca M. ; Zhang, Xu ; Salazar, Jorge ; Gautam, Nischal K.</creator><creatorcontrib>Harris, Andrea D. ; Hubbard, Richard M. ; Sam, Rebecca M. ; Zhang, Xu ; Salazar, Jorge ; Gautam, Nischal K.</creatorcontrib><description>The 3-factor prothrombin complex concentrate (3FPCC) may be used off-label to treat refractory bleeding during cardiac surgery in children. This retrospective study examined the rate of clinical complications following the use of 3FPCC. Patients treated with 3FPCC were matched to controls for age, gender, prematurity, weight, cardiopulmonary bypass times, and cross-clamp times. Fifty-nine cases were individually matched to 59 controls based on propensity scores. 3FPCC was not associated with an increased risk of thromboembolic events, mortality, or need for postoperative extracorporeal membrane oxygenator support. These results suggest the safety of 3FPCC when used for refractory bleeding after cardiopulmonary bypass in children undergoing congenital heart surgery.</description><identifier>ISSN: 1089-2532</identifier><identifier>EISSN: 1940-5596</identifier><identifier>DOI: 10.1177/1089253219899255</identifier><identifier>PMID: 31906821</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><ispartof>Seminars in cardiothoracic and vascular anesthesia, 2020-09, Vol.24 (3), p.227-231</ispartof><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-2f4312ca29ad68e0f40c20a3e1fe65df6fe318b4274ad1de5857fa176e55f27f3</citedby><cites>FETCH-LOGICAL-c337t-2f4312ca29ad68e0f40c20a3e1fe65df6fe318b4274ad1de5857fa176e55f27f3</cites><orcidid>0000-0002-2491-6705</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1089253219899255$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1089253219899255$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31906821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harris, Andrea D.</creatorcontrib><creatorcontrib>Hubbard, Richard M.</creatorcontrib><creatorcontrib>Sam, Rebecca M.</creatorcontrib><creatorcontrib>Zhang, Xu</creatorcontrib><creatorcontrib>Salazar, Jorge</creatorcontrib><creatorcontrib>Gautam, Nischal K.</creatorcontrib><title>A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study</title><title>Seminars in cardiothoracic and vascular anesthesia</title><addtitle>Semin Cardiothorac Vasc Anesth</addtitle><description>The 3-factor prothrombin complex concentrate (3FPCC) may be used off-label to treat refractory bleeding during cardiac surgery in children. This retrospective study examined the rate of clinical complications following the use of 3FPCC. Patients treated with 3FPCC were matched to controls for age, gender, prematurity, weight, cardiopulmonary bypass times, and cross-clamp times. Fifty-nine cases were individually matched to 59 controls based on propensity scores. 3FPCC was not associated with an increased risk of thromboembolic events, mortality, or need for postoperative extracorporeal membrane oxygenator support. These results suggest the safety of 3FPCC when used for refractory bleeding after cardiopulmonary bypass in children undergoing congenital heart surgery.</description><issn>1089-2532</issn><issn>1940-5596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kUtv1DAUhS1ERUthzwp5ySbgR5wHuzCiFKkVqGXWkce-nknl2MF2KvIP-7NwmNIFEqt7pPud48dB6A0l7ymt6w-UNC0TnNG2abMQz9AZbUtSCNFWz7PO62Ldn6KXMd4Rwgij_AU65bQlVcPoGXro8A2k4OMEKg33gDsn7RKHiL3B6QB4G2GVvLiQKvmAvwefDsGPu8HhjR8nC7_ydApcCjJBxCZDN2DCH3zBnyyAHtwedyZBwBsZ9OCn2Y7eyXW9TDJGvIYdBqsDOLx1GsLer55LkCHh2znsISwfcYevZVIH0DkmQpGPzTe3-DbNenmFToy0EV4_znO0vfj8Y3NZXH378nXTXRWK8zoVzJScMiVZK3XVADElUYxIDtRAJbSpDHDa7EpWl1JTDaIRtZG0rkAIw2rDz9G7Y-4U_M8ZYurHISqwVjrwc-wZ5yVjZdXWGSVHVOX_jQFMP4VhzK_uKenX_vp_-8uWt4_p824E_WT4W1gGiiMQ5R76Oz-H3Ff8f-BvizGmHw</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Harris, Andrea D.</creator><creator>Hubbard, Richard M.</creator><creator>Sam, Rebecca M.</creator><creator>Zhang, Xu</creator><creator>Salazar, Jorge</creator><creator>Gautam, Nischal K.</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2491-6705</orcidid></search><sort><creationdate>20200901</creationdate><title>A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study</title><author>Harris, Andrea D. ; Hubbard, Richard M. ; Sam, Rebecca M. ; Zhang, Xu ; Salazar, Jorge ; Gautam, Nischal K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-2f4312ca29ad68e0f40c20a3e1fe65df6fe318b4274ad1de5857fa176e55f27f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harris, Andrea D.</creatorcontrib><creatorcontrib>Hubbard, Richard M.</creatorcontrib><creatorcontrib>Sam, Rebecca M.</creatorcontrib><creatorcontrib>Zhang, Xu</creatorcontrib><creatorcontrib>Salazar, Jorge</creatorcontrib><creatorcontrib>Gautam, Nischal K.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in cardiothoracic and vascular anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harris, Andrea D.</au><au>Hubbard, Richard M.</au><au>Sam, Rebecca M.</au><au>Zhang, Xu</au><au>Salazar, Jorge</au><au>Gautam, Nischal K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study</atitle><jtitle>Seminars in cardiothoracic and vascular anesthesia</jtitle><addtitle>Semin Cardiothorac Vasc Anesth</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>24</volume><issue>3</issue><spage>227</spage><epage>231</epage><pages>227-231</pages><issn>1089-2532</issn><eissn>1940-5596</eissn><abstract>The 3-factor prothrombin complex concentrate (3FPCC) may be used off-label to treat refractory bleeding during cardiac surgery in children. This retrospective study examined the rate of clinical complications following the use of 3FPCC. Patients treated with 3FPCC were matched to controls for age, gender, prematurity, weight, cardiopulmonary bypass times, and cross-clamp times. Fifty-nine cases were individually matched to 59 controls based on propensity scores. 3FPCC was not associated with an increased risk of thromboembolic events, mortality, or need for postoperative extracorporeal membrane oxygenator support. These results suggest the safety of 3FPCC when used for refractory bleeding after cardiopulmonary bypass in children undergoing congenital heart surgery.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>31906821</pmid><doi>10.1177/1089253219899255</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-2491-6705</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1089-2532 |
| ispartof | Seminars in cardiothoracic and vascular anesthesia, 2020-09, Vol.24 (3), p.227-231 |
| issn | 1089-2532 1940-5596 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2334224697 |
| source | SAGE Complete A-Z List |
| title | A Retrospective Analysis of the Use of 3-Factor Prothrombin Complex Concentrates for Refractory Bleeding After Cardiopulmonary Bypass in Children Undergoing Heart Surgery: A Matched Case-Control Study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A36%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Retrospective%20Analysis%20of%20the%20Use%20of%203-Factor%20Prothrombin%20Complex%20Concentrates%20for%20Refractory%20Bleeding%20After%20Cardiopulmonary%20Bypass%20in%20Children%20Undergoing%20Heart%20Surgery:%20A%20Matched%20Case-Control%20Study&rft.jtitle=Seminars%20in%20cardiothoracic%20and%20vascular%20anesthesia&rft.au=Harris,%20Andrea%20D.&rft.date=2020-09-01&rft.volume=24&rft.issue=3&rft.spage=227&rft.epage=231&rft.pages=227-231&rft.issn=1089-2532&rft.eissn=1940-5596&rft_id=info:doi/10.1177/1089253219899255&rft_dat=%3Cproquest_cross%3E2334224697%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2334224697&rft_id=info:pmid/31906821&rft_sage_id=10.1177_1089253219899255&rfr_iscdi=true |